Aily Labs, a Munich, Germany-based company that provides an AI-powered decision intelligence app for global enterprises, has raised €19 million in Series A funding. The round was led by Insight Partners, with participation from existing investors. The company intends to use the funds to scale operations and expand its presence in the United States. It will also use the funds to accelerate innovation in digital solutions and apply GenAI.
Founded in 2020 by CEO Bianca Anghelina, Aily Labs provides a mobile-first app that gives users at all levels real-time insights to make informed, instant decisions. The app uses AI and machine learning to integrate data from across an enterprise, providing a 360° view of performance.
Aily Labs has already seen quick adoption and support from some global brands. For example, Sanofi has rolled out the app at scale, branding it as plai internally. The app is giving Sanofi a holistic view of its business activities, enabling company-wide digital transformation. By leveraging AI, Aily is helping thousands of Sanofi decision-makers make informed decisions to accelerate drug discovery, enhance clinical trial design, and improve manufacturing and supply.
The app is designed to be easy to use, even for users with limited technical skills.
The app can be customized to meet the specific needs of different organizations.
The app is scalable, so it can be used by enterprises of all sizes.
Aily Labs' decision intelligence app is a powerful tool that can help organizations make better decisions faster. The company's recent funding round will allow it to scale its operations and bring its app to more organizations around the world.
